Pure Global

Abbott clinical biochemical aspartate transaminase (activation) test set - Taiwan Registration 3d11dd550c31e263049dd654e8aa642d

Access comprehensive regulatory information for Abbott clinical biochemical aspartate transaminase (activation) test set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 3d11dd550c31e263049dd654e8aa642d and manufactured by FISHER DIAGNOSTICS, A DIVISION OF FISHER SCIENTIFIC COMPANY, LLC, A PART OF THERMO FISHER SCIENTIFIC INC.;; ABBOTT GMBH. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
3d11dd550c31e263049dd654e8aa642d
Registration Details
Taiwan FDA Registration: 3d11dd550c31e263049dd654e8aa642d
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Abbott clinical biochemical aspartate transaminase (activation) test set
TW: ไบžๅŸน่‡จๅบŠ็”ŸๅŒ–ๅคฉ้–€ๅ†ฌๆฐจ้…ธ่ฝ‰่ƒบ้…ถ(ๆดปๅŒ–)ๆชข้ฉ—่ฉฆๅŠ‘็ต„
Risk Class 2

Registration Details

3d11dd550c31e263049dd654e8aa642d

DHA05602584607

Product Details

This product is used in conjunction with the AEROSET system and the ARCHITECT c system (c4000, c8000, c16000) to quantitatively detect aspartate transaminases in human serum or plasma. Performance change: Removed the AEROSET system.

A Clinical chemistry and clinical toxicology

A.1100 ๅคฉ้–€ๅ†ฌ่ƒบ้…ธ่ฝ‰่ƒบ้…ถ่ฉฆ้ฉ—็ณป็ตฑ

Input;; Contract manufacturing

Dates and Status

Jan 08, 2014

Jan 08, 2029